V delta1+ t cells for the treatment of myeloid malignancies

MYPI2026003130A0Undetermined Publication Date: 2021-09-20GAMMADELTA THERAPEUTICS LTD
0 Cites 0 Cited by

Patent Information

Application Number
MYPI2026003130
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Filing Date
2020-03-20
Publication Date
2021-09-20
Patent Text Reader

Abstract

The invention relates to compositions comprising Vδ1+ T cells, for use in treating myeloid malignancies. The present invention also relates to methods of treatment using said compositions. Figure 1
Need to check novelty before this filing date? Find Prior Art